Regulus Therapeutics Inc. financial data

Symbol
RGLS on Nasdaq
Location
San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.46K % +118%
Debt-to-equity 8.01 % -56.6%
Return On Equity -57.5 % +12.4%
Return On Assets -53.3 % +3.93%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 66.2M shares +1.19%
Common Stock, Shares, Outstanding 66.3M shares +1.25%
Entity Public Float 115M USD +319%
Common Stock, Value, Issued 66K USD +1.54%
Weighted Average Number of Shares Outstanding, Basic 66.2M shares +130%
Weighted Average Number of Shares Outstanding, Diluted 66.2M shares +130%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 36.1M USD +62.3%
General and Administrative Expense 15.6M USD +51.5%
Operating Income (Loss) -51.8M USD -58.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.5M USD -51.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -47.5M USD -51.5%
Earnings Per Share, Basic -1 USD/shares +53.1%
Earnings Per Share, Diluted -1 USD/shares +53.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49.5M USD +67.2%
Cash, Cash Equivalents, and Short-term Investments 65.4M USD -39.3%
Other Assets, Current 1.09M USD -11.5%
Assets, Current 71.7M USD -29.3%
Property, Plant and Equipment, Net 1.12M USD +3.22%
Operating Lease, Right-of-Use Asset 1.99M USD +49.5%
Intangible Assets, Net (Excluding Goodwill) 23K USD -23.3%
Other Assets, Noncurrent 21K USD
Assets 74.8M USD -34.4%
Accounts Payable, Current 200K USD -50.7%
Employee-related Liabilities, Current 1.44M USD +21.8%
Accrued Liabilities, Current 808K USD +33.8%
Liabilities, Current 4.4M USD -22.6%
Operating Lease, Liability, Noncurrent 1.4M USD +61.4%
Liabilities 5.8M USD -11.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 10K USD
Retained Earnings (Accumulated Deficit) -569M USD -9.11%
Stockholders' Equity Attributable to Parent 69M USD -35.8%
Liabilities and Equity 74.8M USD -34.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD -21.4%
Net Cash Provided by (Used in) Financing Activities 45K USD -100%
Net Cash Provided by (Used in) Investing Activities 21.5M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 66.3M shares +1.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 10.9M USD +87.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 49.5M USD +67%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD -88.9%
Deferred Tax Assets, Valuation Allowance 153M USD +9.28%
Deferred Tax Assets, Gross 154M USD +9.2%
Operating Lease, Liability 1.99M USD +24.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -47.5M USD -51.1%
Lessee, Operating Lease, Liability, to be Paid 2.48M USD +45.3%
Property, Plant and Equipment, Gross 5.52M USD +4.03%
Operating Lease, Liability, Current 585K USD -19.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 905K USD +227%
Lessee, Operating Lease, Liability, to be Paid, Year One 647K USD -21.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 492K USD +360%
Lessee, Operating Lease, Liability, to be Paid, Year Three 304K USD
Deferred Tax Assets, Operating Loss Carryforwards 95.9M USD +3.54%
Unrecognized Tax Benefits 7.04M USD +12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Depreciation, Depletion and Amortization 85K USD +4.94%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 9M USD +167%
Interest Expense 500K USD -30.4%